Factlen ExplainerLongevity ScienceExplainerJun 24, 2026, 4:05 PM· 6 min read· #2 of 2 in perspectives

The Emerging Consensus on 'Healthspan': What Longevity Experts Agree Actually Works

As the science of aging shifts from extending lifespan to maximizing 'healthspan'—the years lived in good health—a global consensus is forming. While experimental therapies grab headlines, experts agree that targeted exercise, metabolic health, and proactive medicine remain the most potent tools for healthy longevity.

By Factlen Editorial Team

Clinical Longevity Physicians 35%Biogerontologists 35%Public Health Advocates 30%
Clinical Longevity Physicians
Advocate for aggressive, proactive medical interventions and biomarker optimization long before diseases manifest.
Biogerontologists
Focus on understanding and manipulating the fundamental cellular mechanisms of aging to develop targeted therapeutics.
Public Health Advocates
Emphasize the need to democratize healthy aging through systemic changes in environment, education, and healthcare access.

What's not represented

  • · Health Insurance Providers
  • · Regulatory Agencies (FDA/EMA)

Why this matters

Understanding the difference between lifespan and healthspan fundamentally changes how we approach aging. By adopting evidence-based interventions today, individuals can compress the period of illness at the end of life and maintain their independence, mobility, and cognitive function for decades longer.

Key points

  • The focus of aging research has shifted from simply extending life to maximizing the years spent in good health.
  • The average person globally experiences a 9-to-10-year gap between their lifespan and healthspan.
  • Exercise, specifically a combination of aerobic training and heavy resistance training, is the most potent intervention for healthy aging.
  • Preserving muscle mass is critical for metabolic health and preventing frailty.
  • Proactive medicine focuses on early optimization of biomarkers like ApoB rather than waiting for disease onset.
9-10 years
Average global gap between lifespan and healthspan
30 years
Increase in global life expectancy over the past century
14
Identified biological 'hallmarks of aging'

For centuries, humanity's medical ambitions were defined by a single, binary metric: keeping people alive. This relentless pursuit of lifespan extension was spectacularly successful, adding an average of 30 years to global life expectancy over the past century. But as we approach the latter half of the 2020s, a profound shift is reshaping the medical landscape. We have entered what researchers call the "second longevity revolution," where the primary objective is no longer simply extending the duration of life, but maximizing its quality.[1][3]

This paradigm shift centers on a concept known as "healthspan"—the period of life spent in good health, free from chronic disease and debilitating loss of function. While lifespan is easily measured by a birth certificate and a death certificate, healthspan is a spectrum of vitality. Currently, the global data reveals a grim reality: according to recent analyses, the average person experiences a nine-to-ten-year gap between their healthspan and their lifespan. For a decade or more, millions live burdened by frailty, cognitive decline, and metabolic dysfunction.

Closing this gap has become the holy grail of modern medicine. To do so, longevity experts, biogerontologists, and public health officials are moving away from reactive disease management—waiting for a heart attack or dementia to strike before intervening—and toward proactive, preventative maintenance. Through a combination of rigorous clinical trials, massive data analysis, and global expert consensus, a unified framework for extending healthspan is finally emerging.[4][5]

Globally, the average person spends the final 9 to 10 years of their life burdened by chronic disease and declining function.
Globally, the average person spends the final 9 to 10 years of their life burdened by chronic disease and declining function.

At the cellular level, the consensus begins with understanding why our bodies degrade. Researchers have identified 14 "hallmarks of aging," biological processes that drive systemic decline. One of the most heavily researched is cellular senescence. As we age, certain cells stop dividing but refuse to die, lingering in the body and secreting inflammatory signals that damage surrounding tissue.[2][3]

These "zombie cells" are normally cleared by a youthful immune system, but as immune function wanes, they accumulate. In a landmark effort to map this phenomenon, the National Institutes of Health (NIH) recently launched the Cellular Senescence Network (SenNet), publishing the first comprehensive atlas of senescent cells across the human body. Understanding where these cells hide is the foundational step toward developing "senolytics"—experimental drugs designed to selectively clear them out and restore tissue function.[2]

Researchers have identified 14 biological hallmarks that drive the aging process at the cellular level.
Researchers have identified 14 biological hallmarks that drive the aging process at the cellular level.

But while pharmaceutical interventions like senolytics remain largely in the clinical trial phase, experts agree that the most potent healthspan-extending tools are already available. Chief among them is exercise, which is no longer viewed merely as a tool for weight loss, but as a fundamental biological signal that regulates everything from mitochondrial efficiency to cognitive preservation.[4]

A recent global consensus published in The Journal of Nutrition, Health and Aging established specific, evidence-based exercise protocols for healthy longevity. The experts emphasize a multicomponent approach: aerobic training to build cardiovascular capacity, and heavy resistance training to preserve muscle mass and bone density. Muscle is now recognized as a vital endocrine organ and the body's primary "sink" for glucose disposal, making it a critical buffer against metabolic diseases like type 2 diabetes.[4]

A recent global consensus published in The Journal of Nutrition, Health and Aging established specific, evidence-based exercise protocols for healthy longevity.

In fact, clinical longevity physicians increasingly point to two specific metrics as the strongest predictors of a long healthspan: VO2 max (the maximum rate of oxygen consumption during exercise) and physical strength. Poor performance in these areas predicts early mortality more accurately than traditional risk factors like smoking or high blood pressure. Consequently, experts advocate for building a "reserve" of muscle and aerobic capacity in middle age to withstand the inevitable declines of later life.[4]

Cardiovascular fitness and muscle strength are increasingly recognized as the strongest predictors of a long healthspan.
Cardiovascular fitness and muscle strength are increasingly recognized as the strongest predictors of a long healthspan.

Nutrition science, long plagued by fad diets and conflicting studies, is also coalescing around a healthspan-focused consensus. For years, animal studies suggested that severe caloric restriction and low protein intake could extend lifespan by downregulating growth pathways. However, human longevity experts now caution that this approach often backfires in humans by accelerating the loss of lean muscle mass—a condition known as sarcopenia, which is a primary driver of frailty and loss of independence.[4][5]

Instead, the consensus emphasizes metabolic health and the quality of macronutrients. The goal is to maintain insulin sensitivity and minimize systemic inflammation. This involves prioritizing whole foods, minimizing ultra-processed carbohydrates, and ensuring adequate protein intake to support muscle synthesis, particularly as the body becomes less efficient at processing protein with age.[4][5]

Alongside diet and exercise, sleep has been elevated from a passive state of rest to an active, non-negotiable pillar of healthspan. During deep sleep, the brain activates the glymphatic system, a waste-clearance pathway that flushes out neurotoxic proteins, including the amyloid-beta plaques associated with Alzheimer's disease. Chronic sleep deprivation accelerates cognitive decline and disrupts the circadian rhythms that govern metabolic and hormonal balance.[1]

On the clinical frontier, the approach to biomarkers is undergoing a radical transformation. Rather than waiting for cholesterol levels to reach a disease threshold, longevity physicians advocate for the aggressive, early management of apolipoprotein B (ApoB), a protein found on all cholesterol particles that cause arterial plaque. By driving ApoB levels down early in life, experts believe the risk of atherosclerotic cardiovascular disease can be dramatically reduced, if not entirely eliminated.[4]

Hormone optimization is another area of intense focus and ongoing clinical evaluation. As men and women age, physiological declines in hormones like testosterone and estrogen contribute to reductions in bone density, muscle mass, and libido. While hormone replacement therapies were once viewed with skepticism due to flawed historical studies, modern consensus is shifting. When administered carefully and monitored via bloodwork, hormone optimization is increasingly recognized as a valid tool for preserving vitality and function in appropriate candidates.[4][5]

Despite these advances, a critical tension remains: the democratization of longevity. Currently, the most advanced preventative care is often confined to boutique longevity clinics, accessible only to those who can afford substantial out-of-pocket costs. If healthspan interventions remain a luxury good, the gap between the wealthy and the broader population will only widen.

Proactive medicine focuses on optimizing biomarkers and physical capacity long before diseases manifest.
Proactive medicine focuses on optimizing biomarkers and physical capacity long before diseases manifest.

To address this, academic leaders are calling for "Public Health 4.0," a systemic overhaul that integrates healthy longevity principles into mainstream medical curricula and public policy. This framework argues that extending healthspan requires addressing social determinants of health—such as access to green spaces, clean air, and nutritious food—just as aggressively as we target cellular aging.

Ultimately, the science of healthspan offers a profoundly optimistic view of human aging. Decline is not an inevitable cliff we fall off, but a curve we can actively bend. By shifting our focus from merely surviving to thriving, and by applying the consensus tools of exercise, metabolic optimization, and proactive medicine, we possess the unprecedented ability to ensure our final decades are defined by vitality rather than vulnerability.[1][3][5]

How we got here

  1. Early 2000s

    Longevity research primarily focuses on genetic manipulation and severe caloric restriction in animal models to extend absolute lifespan.

  2. 2013

    Researchers publish the seminal 'Hallmarks of Aging' paper, establishing a unified framework for understanding cellular decline.

  3. 2021

    The NIH launches the Cellular Senescence Network (SenNet) to map 'zombie cells' across the human body.

  4. 2024-2025

    Global health organizations and academic institutions formally pivot toward 'healthspan' and preventative medicine as the primary goals of public health.

  5. June 2026

    The NIH publishes the first comprehensive atlas of senescent cells, paving the way for targeted human therapies.

Viewpoints in depth

Clinical Longevity Physicians

Advocate for aggressive, proactive medical interventions and biomarker optimization long before diseases manifest.

This camp argues that the traditional medical system is designed to treat diseases only after they have caused significant damage. Longevity physicians push for 'Medicine 3.0,' a paradigm that relies on early, aggressive intervention. They prioritize tracking advanced biomarkers, such as ApoB for cardiovascular risk and continuous glucose monitors for metabolic health, and are willing to utilize pharmaceuticals like statins, rapamycin, or hormone replacement therapy off-label to optimize a patient's physiological state decades before a crisis occurs.

Biogerontologists

Focus on understanding and manipulating the fundamental cellular mechanisms of aging to develop targeted therapeutics.

Researchers in this field view aging not as an inevitable decline, but as a biological process driven by specific, targetable mechanisms—the 'hallmarks of aging.' Their work centers on developing interventions that address the root causes of cellular decay, such as mitochondrial dysfunction, genomic instability, and cellular senescence. They argue that while lifestyle interventions are crucial, true breakthroughs in healthspan will come from next-generation therapeutics, like senolytics or epigenetic reprogramming, which can fundamentally repair age-related damage at the molecular level.

Public Health Advocates

Emphasize the need to democratize healthy aging through systemic changes in environment, education, and healthcare access.

Public health experts caution against a future where healthspan extension is a luxury available only to those who can afford boutique clinics and expensive diagnostics. They argue that the most significant gains in population healthspan will come from addressing the social determinants of health. This camp advocates for policy-level interventions: redesigning cities to encourage natural movement, regulating ultra-processed foods, improving air quality, and ensuring equitable access to preventative care, arguing that a society's longevity success should be measured by its most vulnerable populations.

What we don't know

  • The long-term efficacy and safety of emerging anti-aging pharmaceuticals, such as senolytics, in healthy human populations.
  • How to perfectly balance protein intake to maximize muscle preservation without overstimulating cellular growth pathways.
  • When, or if, the classification of aging itself will be universally recognized as a treatable disease by regulatory bodies.

Key terms

Healthspan
The period of a person's life spent in good health, free from chronic disease and debilitating loss of function.
Cellular Senescence
A state in which cells stop dividing but do not die, accumulating in the body and secreting inflammatory signals that damage surrounding tissue.
Senolytics
A class of experimental drugs designed to selectively target and eliminate senescent 'zombie' cells from the body.
VO2 Max
The maximum rate at which the heart, lungs, and muscles can effectively use oxygen during exercise; a strong predictor of longevity.
Apolipoprotein B (ApoB)
A protein found on all cholesterol particles that cause arterial plaque; considered a more accurate marker of cardiovascular risk than LDL cholesterol alone.
Sarcopenia
The age-related, involuntary loss of skeletal muscle mass and strength, which significantly increases the risk of frailty and falls.

Frequently asked

What is the difference between lifespan and healthspan?

Lifespan is the total number of years a person lives, while healthspan is the number of those years spent in good health, free from chronic disease and disability.

Can I increase my healthspan without taking experimental drugs?

Yes. Experts agree that lifestyle interventions—specifically rigorous exercise, adequate protein intake, and optimized sleep—are currently the most powerful tools for extending healthspan.

Why is muscle mass so important for aging?

Muscle acts as a metabolic sink for glucose, helping to prevent insulin resistance. It also protects joints, preserves mobility, and prevents the frailty that often leads to fatal falls in older adults.

What are senescent cells?

Often called 'zombie cells,' these are damaged cells that stop dividing but refuse to die. They accumulate with age and release inflammatory chemicals that accelerate tissue degradation.

Sources

Source coverage

5 outlets

3 viewpoints surfaced

Clinical Longevity Physicians 35%Biogerontologists 35%Public Health Advocates 30%
  1. [1]Factlen Editorial Team

    Synthesis by Factlen editorial team

    Read on Factlen Editorial Team
  2. [2]National Institutes of Health (NIH)Biogerontologists

    NIH research establishes new framework for the role of senescence in aging

    Read on National Institutes of Health (NIH)
  3. [3]McKinsey Health InstituteBiogerontologists

    Healthspan science: The pursuit of extending healthspan and improving function

    Read on McKinsey Health Institute
  4. [4]The Peter Attia DriveClinical Longevity Physicians

    Latest insights on Alzheimer's disease, cancer, exercise, nutrition, and fasting

    Read on The Peter Attia Drive
  5. [5]Aging and Disease

    Healthspan-Oriented Care: A Delphi-Derived Expert Consensus

    Read on Aging and Disease
Stay informed

Every angle. Every day.

Get perspectives stories with full source coverage and perspective breakdowns delivered to your inbox.